...maximise and sustain research performance

Scientific Advisory Board

The aims of the Scientific Advisory Board:

To enhance communications and mutually beneficial collaborations between The Faculty of Biology, Medicine and Health, and Industry.

To implement strategies and policies which maximise and sustain research performance, research income, and quality of infrastructure at the Centre and to keep in touch with current research activities and the needs of industry / academia.

To improve access to facilities and funding opportunities and also improve graduate and postgraduate employment opportunities.

Board members:

Professor Peter C Doherty

Department of Microbiology and Immunology, University of Melbourne, Vic 3010, Australia;

Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.


Professor Michael Dustin

Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Headington, Oxfordshire, UK;

Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, USA; Department of Pathology, New York University School of Medicine, New York, USA.


Professor Sir Marc Feldmann

The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.


Professor David Wraith

School of Cellular and Molecular Medicine, University of Bristol, Medical Sciences Building, Bristol, BS8 1TD


AstraZeneca logo GlaxoSmithKline logo